Freeline Therapeutics Holdings PLC ADR (FRLN) Social Stream
FREELINE THERAPEUTICS HOLDINGS PLC (FRLN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering FREELINE THERAPEUTICS HOLDINGS PLC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 7 | $27 | $8 | $16.285 | $6.4 | 154.45% |
| 2021-11-15 | 7 | $27 | $8 | $16 | $6.4 | 150% |
| 2021-11-29 | 8 | $27 | $8 | $15.25 | $6.4 | 138.28% |
| 2021-12-14 | 8 | $27 | $8 | $15.857 | $6.4 | 147.77% |
| 2021-12-16 | 8 | $27 | $8 | $15 | $6.4 | 134.37% |
| 2021-12-17 | 8 | $27 | $8 | $14.125 | $6.4 | 120.7% |
| 2022-02-01 | 8 | $27 | $2 | $13.25 | $6.4 | 107.03% |
| 2022-03-09 | 7 | $27 | $2 | $13.25 | $6.4 | 107.03% |
| 2022-03-31 | 6 | $20 | $2 | $11.285 | $6.4 | 76.33% |
| 2022-04-04 | 7 | $20 | $2 | $11.285 | $6.4 | 76.33% |
| 2022-04-12 | 7 | $20 | $2 | $10.428 | $6.4 | 62.94% |
| 2022-05-13 | 5 | $20 | $2 | $9.6 | $6.4 | 50% |
| 2022-08-09 | 5 | $20 | $2 | $9 | $6.4 | 40.62% |
| 2022-08-11 | 5 | $20 | $2 | $8 | $6.4 | 25% |
| 2022-11-15 | 5 | $15 | $2 | $5.4 | $6.4 | -15.62% |
| 2022-11-22 | 4 | $15 | $2 | $6.25 | $6.4 | -2.34% |
| 2023-04-05 | 4 | $74.626 | $14.925 | $33.581 | $6.4 | 424.7% |
| 2023-06-01 | 4 | $74.626 | $3 | $24.406 | $6.4 | 281.34% |
| 2023-08-15 | 3 | $15 | $3 | $7.666 | $6.4 | 19.78% |
| 2023-08-17 | 3 | $15 | $4 | $8 | $6.4 | 25% |
| 2023-10-04 | 3 | $15 | $4 | $9 | $6.4 | 40.62% |
| 2023-10-18 | 3 | $15 | $4 | $8 | $6.4 | 25% |
| 2023-10-27 | 2 | $15 | $4 | $9.5 | $6.4 | 48.44% |
| 2023-11-27 | 2 | $15 | $6.5 | $10.75 | $6.4 | 67.97% |
| 2023-11-28 | 1 | $6.5 | $6.5 | $6.5 | $6.4 | 1.56% |
Price Target Last Issued November 28, 2023
The Trend in the Analyst Price Target
FRLN's average price target has moved down $22.25 over the prior 39 months.
Over the past 34 weeks, FRLN's average upside potential has been 595.89%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-05 | 4 | 74.626 | 14.925 | 33.581 | 0.46 | 7200.22% |
| 2023-06-01 | 4 | 15.000 | 3.000 | 7.666 | 2.50 | 206.64% |
| 2023-06-01 | 3 | 15.000 | 3.000 | 7.666 | 2.50 | 206.64% |
| 2023-06-01 | 4 | 74.626 | 3.000 | 24.406 | 2.50 | 876.24% |
| 2023-08-17 | 2 | 15.000 | 4.000 | 9.500 | 4.27 | 122.48% |
FRLN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 153 days, FRLN's average broker recommendation rating worsened by 1.33.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how FREELINE THERAPEUTICS HOLDINGS PLC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2580.79% of that group.
- To contextualize these metrics, consider that out of all US stocks, FREELINE THERAPEUTICS HOLDINGS PLC's average analyst price target is greater than 390.34% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, FREELINE THERAPEUTICS HOLDINGS PLC's number of analysts covering the stock is greater than 1629.32% of them.
- FRLN has a greater upside potential (average analyst target price relative to current price) than 1255.5% of stocks in the small market cap category.
In the Pharmaceutical Products industry, INBX, ATHA, and HUMA are the three stocks most similar to FREELINE THERAPEUTICS HOLDINGS PLC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for FRLN? Use POWR Ratings for clearer insight into price direction.